Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NP2 for intractable pain due to malignancy
NCT01291901Phase 2Completed
- Sponsor
- Diamyd Medical
- Start
- Jan 2011
- Primary completion
- Jul 2012
- Modality
- Gene Editing, Gene Silencing, Viral Vectors
- Countries
- 1
01
Overview
A Phase 2 trial of NP2 Enkephalin in pain, sponsored by Diamyd Medical. Started Jan 2011; status: completed.
02
Drugs
NP2 Enkephalin
03
Conditions
pain
Beyond the preview
Go deeper on NCT01291901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01291901.